| Astrazeneca Pharma India Ltd | 18,080 Cr. | 7,232 | 9,850/7,194 | 104 | 349 | 0.50 % | 29.3 % | 23.3 % | 2.00 |
| ERIS Lifesciences Ltd | 18,371 Cr. | 1,326 | 1,819/1,200 | 28.0 | 282 | 0.54 % | 14.1 % | 18.7 % | 1.00 |
| Caplin Point Laboratories Ltd | 18,973 Cr. | 2,496 | 2,700/1,500 | 28.5 | 472 | 0.32 % | 24.6 % | 20.6 % | 2.00 |
| Cohance Lifesciences Ltd | 17,169 Cr. | 449 | 1,039/267 | 159 | 102 | 0.00 % | 8.35 % | 7.04 % | 1.00 |
| Shilpa Medicare Ltd | 16,738 Cr. | 856 | 867/260 | 58.9 | 132 | 0.07 % | 10.9 % | 8.99 % | 1.00 |
| Concord Biotech Ltd | 16,116 Cr. | 1,540 | 1,748/987 | 56.7 | 193 | 0.49 % | 17.4 % | 12.6 % | 1.00 |
| Alembic Pharmaceuticals Ltd | 16,057 Cr. | 817 | 998/635 | 21.5 | 289 | 1.47 % | 12.6 % | 13.4 % | 2.00 |
| Natco Pharma Ltd | 15,834 Cr. | 884 | 1,227/789 | 13.8 | 515 | 0.57 % | 17.1 % | 16.9 % | 2.00 |
| Granules India Ltd | 21,194 Cr. | 855 | 910/456 | 32.6 | 205 | 0.20 % | 15.5 % | 13.8 % | 1.00 |
| Marksans Pharma Ltd | 14,678 Cr. | 324 | 346/155 | 28.4 | 66.7 | 0.28 % | 18.8 % | 15.2 % | 1.00 |
| Jubilant Pharmova Ltd | 14,380 Cr. | 903 | 1,185/784 | 37.1 | 445 | 0.55 % | 8.99 % | 6.53 % | 1.00 |
| Pfizer Ltd | 22,332 Cr. | 4,882 | 5,578/4,360 | 29.0 | 919 | 1.54 % | 24.1 % | 18.0 % | 10.0 |
| Blue Jet Healthcare Ltd | 11,110 Cr. | 587 | 760/325 | 47.3 | 78.4 | 0.20 % | 26.1 % | 19.4 % | 2.00 |
| Suven Life Sciences Ltd | 10,448 Cr. | 370 | 394/124 | | 22.4 | 0.00 % | 79.5 % | 81.5 % | 1.00 |
| Acutaas Chemicals Ltd | 25,965 Cr. | 3,171 | 3,740/1,290 | 67.2 | 202 | 0.05 % | 31.6 % | 24.0 % | 5.00 |
| Procter & Gamble Health Ltd | 9,750 Cr. | 5,874 | 6,975/4,700 | 29.3 | 316 | 2.64 % | 83.9 % | 61.9 % | 10.0 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Aarti Pharmalabs Ltd | 7,646 Cr. | 843 | 946/584 | 35.5 | 234 | 0.42 % | 10.7 % | 8.59 % | 5.00 |
| Sanofi India Ltd | 7,541 Cr. | 3,275 | 5,246/3,054 | 22.0 | 359 | 2.29 % | 57.5 % | 43.0 % | 10.0 |
| Entero Healthcare Solutions Ltd | 6,810 Cr. | 1,565 | 1,620/944 | 52.8 | 388 | 0.00 % | 10.5 % | 6.94 % | 10.0 |
| Neuland Laboratories Ltd | 29,387 Cr. | 22,905 | 23,899/11,500 | 59.0 | 1,461 | 0.15 % | 26.5 % | 21.2 % | 10.0 |
| Orchid Pharma Ltd | 6,217 Cr. | 1,038 | 1,133/471 | 344 | 254 | 0.00 % | 1.73 % | 1.35 % | 10.0 |
| Bliss GVS Pharma Ltd | 6,003 Cr. | 565 | 602/118 | 43.6 | 113 | 0.27 % | 16.9 % | 11.8 % | 1.00 |
| FDC Ltd | 5,606 Cr. | 344 | 528/313 | 18.2 | 153 | 1.45 % | 16.7 % | 12.5 % | 1.00 |
| Wockhardt Ltd | 30,890 Cr. | 1,901 | 2,422/1,087 | 77.5 | 304 | 0.00 % | 7.55 % | 6.11 % | 5.00 |
| Morepen Laboratories Ltd | 5,218 Cr. | 95.2 | 98.3/33.0 | 44.4 | 22.8 | 0.21 % | 8.05 % | 6.20 % | 2.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 4,963 Cr. | 169 | 180/67.1 | 28.1 | 61.3 | 0.59 % | 11.3 % | 8.42 % | 2.00 |
| Gujarat Themis Biosyn Ltd | 4,415 Cr. | 405 | 479/225 | 90.7 | 26.4 | 0.16 % | 17.9 % | 17.4 % | 1.00 |
| RPG Life Sciences Ltd | 4,339 Cr. | 2,623 | 3,082/1,731 | 37.2 | 366 | 0.91 % | 25.7 % | 19.3 % | 8.00 |
| Gufic BioSciences Ltd | 4,192 Cr. | 418 | 448/268 | 57.0 | 66.2 | 0.02 % | 12.2 % | 9.98 % | 1.00 |
| Aarti Drugs Limited | 3,843 Cr. | 421 | 535/319 | 22.2 | 154 | 0.48 % | 11.6 % | 12.7 % | 10.0 |
| Zota Health Care Ltd | 3,791 Cr. | 1,094 | 1,740/1,026 | | 200 | 0.09 % | 8.47 % | 15.0 % | 10.0 |
| Unichem Laboratories Ltd | 3,589 Cr. | 510 | 687/278 | 29.4 | 386 | 0.00 % | 4.13 % | 3.17 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 3,582 Cr. | 3,452 | 3,744/829 | 43.9 | 321 | 0.00 % | 23.9 % | 22.5 % | 10.0 |
| Advanced Enzyme Technologies Ltd | 3,386 Cr. | 302 | 420/252 | 21.5 | 146 | 1.77 % | 14.0 % | 10.2 % | 2.00 |
| SMS Pharmaceuticals Ltd | 3,316 Cr. | 354 | 448/221 | 36.6 | 85.9 | 0.11 % | 12.9 % | 11.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 3,007 Cr. | 629 | 712/422 | 704 | 346 | 0.00 % | 4.86 % | 0.13 % | 10.0 |
| Ind-Swift Laboratories Ltd | 2,846 Cr. | 327 | 351/87.0 | 43.7 | 159 | 0.00 % | 4.70 % | 3.87 % | 10.0 |
| Dishman Carbogen Amcis Ltd | 2,716 Cr. | 173 | 322/128 | 150 | 426 | 0.00 % | 3.15 % | 1.58 % | 2.00 |
| Hikal Ltd | 2,614 Cr. | 212 | 283/146 | 61.6 | 97.2 | 0.09 % | 3.52 % | 2.95 % | 2.00 |
| Beta Drugs Ltd | 2,558 Cr. | 2,307 | 2,808/990 | 56.1 | 241 | 0.00 % | 19.2 % | 18.8 % | 10.0 |
| Panacea Biotec Ltd | 2,488 Cr. | 406 | 648/292 | | 136 | 0.00 % | 2.44 % | 2.36 % | 1.00 |
| Fredun Pharmaceuticals Ltd | 2,401 Cr. | 1,452 | 1,600/377 | 54.0 | 170 | 0.02 % | 21.5 % | 15.8 % | 10.0 |
| Venus Remedies Ltd | 2,255 Cr. | 1,687 | 2,044/424 | 19.4 | 497 | 0.59 % | 21.7 % | 16.8 % | 10.0 |
| Indoco Remedies Ltd | 2,023 Cr. | 219 | 332/162 | | 102 | 0.09 % | 0.93 % | 9.42 % | 2.00 |
| Hester Biosciences Ltd | 2,011 Cr. | 2,364 | 2,684/1,239 | 37.9 | 423 | 0.47 % | 15.2 % | 15.9 % | 10.0 |
| Syncom Formulations (India) Ltd | 1,615 Cr. | 17.2 | 18.7/10.2 | 19.0 | 4.39 | 0.58 % | 26.8 % | 20.2 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,587 Cr. | 241 | 265/155 | 33.8 | 41.2 | 1.66 % | 22.7 % | 17.3 % | 2.00 |
| TTK Healthcare Ltd | 1,572 Cr. | 1,113 | 1,255/735 | 20.5 | 789 | 0.90 % | 8.04 % | 6.30 % | 10.0 |
| Amrutanjan Health Care Ltd | 1,509 Cr. | 522 | 791/483 | 24.3 | 128 | 0.94 % | 24.8 % | 18.5 % | 1.00 |
| Fermenta Biotech Ltd | 1,373 Cr. | 467 | 580/249 | 25.1 | 138 | 0.80 % | 20.6 % | 16.4 % | 5.00 |
| Lincoln Pharmaceuticals Ltd | 1,226 Cr. | 612 | 770/440 | 12.7 | 378 | 0.29 % | 16.3 % | 12.3 % | 10.0 |
| Themis Medicare Ltd | 1,113 Cr. | 121 | 148/65.0 | | 43.3 | 0.41 % | 2.74 % | 0.41 % | 1.00 |
| Kopran Ltd | 936 Cr. | 194 | 219/107 | 37.5 | 110 | 1.55 % | 6.65 % | 4.91 % | 10.0 |
| Wanbury Ltd | 934 Cr. | 267 | 360/162 | 21.7 | 18.1 | 0.00 % | 36.6 % | 76.5 % | 10.0 |
| Anuh Pharma Ltd | 787 Cr. | 78.5 | 93.0/66.7 | 17.8 | 35.1 | 1.91 % | 14.9 % | 10.7 % | 5.00 |
| Bafna Pharmaceuticals Ltd | 602 Cr. | 255 | 296/94.8 | 77.3 | 40.6 | 0.00 % | 11.9 % | 12.3 % | 10.0 |
| Kilitch Drugs (India) Ltd | 583 Cr. | 167 | 220/117 | 19.4 | 80.0 | 0.00 % | 13.4 % | 10.6 % | 10.0 |
| Albert David Ltd | 507 Cr. | 889 | 903/580 | 22.5 | 686 | 0.56 % | 0.82 % | 0.44 % | 10.0 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Gennex Laboratories Ltd | 301 Cr. | 12.4 | 17.2/7.05 | 16.0 | 9.16 | 0.00 % | 10.8 % | 9.25 % | 1.00 |
| Everest Organics Ltd | 297 Cr. | 298 | 536/197 | 56.5 | 77.7 | 0.00 % | 12.0 % | 7.63 % | 10.0 |
| BDH Industries Ltd | 296 Cr. | 513 | 610/280 | 25.3 | 134 | 0.97 % | 20.5 % | 14.8 % | 10.0 |
| Lyka Labs Ltd | 271 Cr. | 75.1 | 105/44.1 | | 25.9 | 0.00 % | 5.98 % | 10.2 % | 10.0 |
| Aarey Drugs & Pharmaceuticals Ltd | 241 Cr. | 78.1 | 100/50.3 | 57.8 | 53.0 | 0.00 % | 5.58 % | 2.75 % | 10.0 |
| Coral Laboratories Ltd | 233 Cr. | 654 | 679/360 | 12.3 | 585 | 0.31 % | 11.0 % | 7.88 % | 10.0 |
| Nectar Lifescience Ltd | 208 Cr. | 10.7 | 22.5/9.20 | | 30.0 | 0.00 % | 0.05 % | 31.3 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Brooks Laboratories Ltd | 182 Cr. | 61.7 | 164/36.3 | 13.8 | 41.6 | 0.00 % | 21.2 % | 22.0 % | 10.0 |
| Achyut Healthcare Ltd | 169 Cr. | 7.00 | 10.0/4.70 | 528 | 1.45 | 0.00 % | 1.23 % | 0.96 % | 1.00 |
| Gujarat Inject (Kerala) Ltd | 168 Cr. | 11.5 | 14.3/1.90 | 56.2 | 0.81 | 0.00 % | 22.9 % | 16.6 % | 1.00 |
| Auro Laboratories Ltd | 146 Cr. | 234 | 317/159 | 30.4 | 74.4 | 0.00 % | 9.52 % | 8.49 % | 10.0 |
| Bal Pharma Ltd | 136 Cr. | 85.2 | 99.0/59.7 | 18.8 | 51.6 | 1.41 % | 9.69 % | 7.87 % | 10.0 |
| Alpa Laboratories Ltd | 130 Cr. | 61.7 | 100/46.0 | 29.7 | 93.4 | 0.00 % | 8.91 % | 7.90 % | 10.0 |
| Lactose (India) Ltd | 125 Cr. | 99.0 | 137/76.0 | 18.0 | 51.5 | 0.00 % | 11.3 % | 9.81 % | 10.0 |
| Par Drugs & Chemicals Ltd | 125 Cr. | 101 | 122/78.0 | 8.61 | 91.0 | 0.00 % | 16.5 % | 12.4 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 115 Cr. | 53.2 | 82.5/38.3 | | 75.5 | 0.00 % | 15.4 % | % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 108 Cr. | 30.7 | 66.0/25.6 | | 13.5 | 0.00 % | 18.5 % | 26.5 % | 10.0 |
| Godavari Drugs Ltd | 106 Cr. | 97.0 | 135/69.7 | 27.2 | 74.8 | 0.00 % | 6.69 % | 6.38 % | 10.0 |
| Concord Drugs Ltd | 101 Cr. | 76.7 | 92.5/56.0 | 49.5 | 36.8 | 0.00 % | 5.24 % | 2.52 % | 10.0 |
| J B Chemicals & Pharmaceuticals Ltd | 38,677 Cr. | 2,409 | 2,526/1,603 | 53.8 | 259 | 0.91 % | 25.4 % | 18.9 % | 1.00 |
| Ajanta Pharma Ltd | 44,734 Cr. | 3,580 | 3,797/2,330 | 39.4 | 362 | 0.89 % | 34.5 % | 27.1 % | 2.00 |
| Gland Pharma Ltd | 46,217 Cr. | 2,802 | 3,040/1,574 | 32.7 | 656 | 0.71 % | 17.4 % | 12.8 % | 1.00 |
| Ipca Laboratories Ltd | 48,721 Cr. | 1,920 | 1,945/1,252 | 35.5 | 318 | 0.31 % | 17.0 % | 15.7 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 49,665 Cr. | 2,932 | 3,055/2,088 | 47.2 | 134 | 1.94 % | 61.4 % | 45.6 % | 10.0 |
| Abbott India Ltd | 56,142 Cr. | 26,420 | 32,775/25,150 | 34.8 | 2,247 | 1.99 % | 44.8 % | 34.4 % | 10.0 |
| Alkem Laboratories Ltd | 63,967 Cr. | 5,350 | 5,934/5,075 | 28.1 | 1,156 | 0.99 % | 21.2 % | 18.9 % | 2.00 |
| Biocon Ltd | 66,720 Cr. | 409 | 447/337 | 91.7 | 210 | 0.12 % | 3.61 % | 1.40 % | 5.00 |
| Glenmark Pharmaceuticals Ltd | 67,471 Cr. | 2,391 | 2,474/1,793 | 21.6 | 372 | 0.21 % | 39.8 % | 23.6 % | 1.00 |
| Glenmark Life Sciences Ltd | 67,703 Cr. | 2,399 | 2,474/1,793 | 21.7 | 372 | 0.21 % | 39.8 % | 23.6 % | 1.00 |
| Aurobindo Pharma Ltd | 92,529 Cr. | 1,608 | 1,682/1,016 | 24.5 | 652 | 0.25 % | 12.9 % | 10.1 % | 1.00 |
| Laurus Labs Ltd | 97,310 Cr. | 1,801 | 1,871/823 | 112 | 97.3 | 0.11 % | 16.0 % | 15.2 % | 2.00 |
| Mankind Pharma Ltd | 97,597 Cr. | 2,363 | 2,674/1,910 | 43.2 | 397 | 0.04 % | 13.7 % | 13.8 % | 1.00 |
| Dr Reddys Laboratories Ltd | 99,326 Cr. | 1,190 | 1,415/1,080 | 30.8 | 454 | 0.67 % | 13.0 % | 11.2 % | 1.00 |
| Lupin Ltd | 1,00,042 Cr. | 2,188 | 2,530/1,875 | 16.8 | 491 | 0.82 % | 29.9 % | 28.7 % | 2.00 |
| Cipla Ltd | 1,16,161 Cr. | 1,438 | 1,673/1,166 | 32.5 | 426 | 0.90 % | 15.5 % | 11.6 % | 2.00 |
| Torrent Pharmaceuticals Ltd | 1,85,867 Cr. | 4,886 | 5,250/3,480 | 83.3 | 248 | 0.78 % | 15.2 % | 27.4 % | 5.00 |
| Sun Pharmaceuticals Industries Ltd | 4,58,273 Cr. | 1,910 | 2,048/1,547 | 36.3 | 348 | 0.84 % | 20.5 % | 16.0 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 52.6 Cr. | 32.3 | 46.8/25.6 | 110 | 13.2 | 0.00 % | 15.8 % | 13.8 % | 10.0 |
| Ganga Pharmaceuticals Ltd | 7.09 Cr. | 12.0 | 14.6/9.35 | 70.9 | 14.1 | 0.00 % | 2.90 % | 1.30 % | 10.0 |
| Bacil Pharma Ltd | 16.5 Cr. | 11.5 | 61.8/11.0 | 25.4 | 17.3 | 0.00 % | 3.93 % | 6.21 % | 10.0 |
| Fervent Synergies Ltd | 75.8 Cr. | 15.2 | 26.0/13.0 | 20.8 | 11.4 | 0.00 % | 7.21 % | 7.22 % | 10.0 |
| Beryl Drugs Ltd | 11.3 Cr. | 22.2 | 30.0/15.9 | 18.2 | 19.5 | 0.00 % | 7.18 % | 4.33 % | 10.0 |
| Colinz Laboratories Ltd | 8.95 Cr. | 71.0 | 87.9/36.1 | 17.9 | 39.9 | 0.00 % | 7.20 % | 5.23 % | 10.0 |
| Checkpoint Trends Ltd | 20.8 Cr. | 38.0 | 144/28.2 | 16.9 | 42.5 | 0.00 % | 15.0 % | 12.7 % | 10.0 |
| Gujarat Terce Laboratories Ltd | 27.8 Cr. | 35.7 | 59.8/29.0 | 12.5 | 12.5 | 0.00 % | 39.2 % | 30.2 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 37.6 Cr. | 49.9 | 55.0/29.7 | 12.3 | 43.9 | 0.00 % | 12.1 % | 9.67 % | 10.0 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | / | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Brawn Biotech Ltd | 6.95 Cr. | 23.2 | 24.4/17.7 | 8.18 | 14.5 | 0.00 % | 0.00 % | 24.4 % | 10.0 |
| Dipna Pharmachem Ltd | 15.5 Cr. | 5.90 | 25.0/3.90 | 5.90 | 23.7 | 0.00 % | 7.64 % | 5.22 % | 10.0 |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 0.79/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| MPS Pharmaa Ltd | 3.80 Cr. | 1.99 | 2.08/1.57 | | 0.04 | 0.00 % | 13.1 % | 177 % | 10.0 |
| Fabino Enterprises Ltd | 4.27 Cr. | 20.3 | 27.0/13.0 | | 18.7 | 0.00 % | 6.22 % | 8.76 % | 10.0 |
| Evoq Remedies Ltd | 4.38 Cr. | 1.76 | 6.11/1.63 | | 17.8 | 0.00 % | 0.56 % | 0.54 % | 10.0 |
| Decipher Labs Ltd | 5.76 Cr. | 5.70 | 11.2/5.00 | | 20.5 | 0.00 % | 16.7 % | 14.2 % | 10.0 |
| Cian Healthcare Ltd | 25.0 Cr. | 10.0 | 10.0/3.17 | | 3.42 | 0.00 % | 15.5 % | 49.2 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 13.3 Cr. | 88.7 | 153/72.0 | | 8.60 | 0.00 % | 164 % | 164 % | 10.0 |
| Bharat Immunological & Biological Corporation Ltd | 68.2 Cr. | 15.8 | 23.1/14.1 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| ANG Lifesciences India Ltd | 32.6 Cr. | 25.0 | 49.7/17.6 | | 47.6 | 0.00 % | 0.95 % | 7.33 % | 10.0 |
| Amerise Biosciences Ltd | 5.55 Cr. | 0.84 | 1.03/0.50 | | 0.82 | 0.00 % | 0.37 % | 0.37 % | 1.00 |
| Adline Chem Lab Ltd | 6.22 Cr. | 10.6 | 17.1/7.60 | | 3.03 | 0.00 % | 933 % | % | 10.0 |
| Vivimed Labs Ltd | 54.3 Cr. | 6.55 | 29.4/4.75 | | 25.4 | 0.00 % | 65.2 % | % | 2.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Industry Average | 23,072.45 Cr | 1,307.39 | | 54.56 | 215.82 | 0.36% | 25.34% | 18.37% | 6.02 |